1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Brentuximab vedotin for treating CD30-positive cutaneous T-cell lymphoma

Technology appraisal guidance [TA577] Published: 24 April 2019

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Evaluation report  
  • Appraisal consultation committee papers PDF 8.04 MB 24 April 2019  
  • Final appraisal determination committee papers PDF 1.2 MB 24 April 2019